Condition
Farsightedness
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting1
Recruiting1
Unknown1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07838597Not ApplicableNot Yet Recruiting
The Emmetropization Via Accommodation (EVA) - II Study
NCT02576483Recruiting
An Evaluation of LASIK, SMILE and PRK Surgery in Physicians
NCT00472212Not ApplicableCompleted
Correction of Farsightedness in Children Study
NCT00778570Unknown
Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)
NCT00574717Phase 1Terminated
Enhancement of Emmetropization in Hyperopic Infants
Showing all 5 trials